← Leaderboards
Philip R Johnson
Children'S Hospital (Columbus)
$4,471,722
Attributed
$4,471,722
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$6,675,079 · 8
By mechanism
P01$3,880,905 · 5
R01$2,294,174 · 1
G20$500,000 · 1
N01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentAids VaccinesVector VaccineSimian Immunodeficiency VirusDrug Screening /EvaluationTransfection /Expression VectorAdeno Associated Virus GroupHumoral ImmunityHuman Immunodeficiency Virus 1RepliconVenezuelan Equine Encephalitis VirusMacacaRecombinant VirusNonhuman Therapy EvaluationMacaca MulattaAntibodyNeutralizing AntibodyActive ImmunizationMolecular CloningHuman Immunodeficiency Virus 2TransfectionDrug Delivery SystemsHiv Envelope Protein Gp160Virus Antigen
Grant awards (19)
Immunoprophylaxis By Gene Transfer: Shortcut To An HIV Vaccine$1,147,087
R01 · FY2014 · AI · contact PI
Immunoprophylaxis By Gene Transfer: Shortcut To An HIV Vaccine$1,147,087
R01 · FY2013 · AI · contact PI
Installation of Energy-Efficient Cage Washers for Childrens Hospital Vivarium$500,000
G20 · FY2012 · OD · contact PI
Novel Prophylactic HIV Vaccines Based on rAAV Vectors$724,215
P01 · FY2005 · AI
Optimization of rAAV Vector Strategies for HIV$703,121
P01 · FY2004 · AI
Novel Prophylactic HIV Vaccines Based on rAAV Vectors$569,535
P01 · FY2004 · AI
Novel Prophylactic HIV Vaccines Based on rAAV Vectors$133,586
P01 · FY2004 · AI
Novel Prophylactic HIV Vaccines Based on rAAV Vectors$776,021
P01 · FY2003 · AI
CORRELATES OF EFFICACY OF VEE-BASED SIV VACCINES$0
P01 · FY2002 · AI
NOVEL VIRAL VECTORS FOR AIDS VACCINES$0
P01 · FY2002 · AI
CORE--PRIMATE FACILITY FOR TESTING VEE-BASED SIV VACCINES$0
P01 · FY2002 · AI
CORE--PRIMATE FACILITY FOR TESTING VEE-BASED SIV VACCINES$0
P01 · FY2001 · AI
CORRELATES OF EFFICACY OF VEE-BASED SIV VACCINES$0
P01 · FY2001 · AI
NOVEL VIRAL VECTORS FOR AIDS VACCINES$0
P01 · FY2001 · AI
NOVEL VIRAL VECTORS FOR AIDS VACCINES$0
P01 · FY2001 · AI
CORE--PRIMATE FACILITY FOR TESTING VEE-BASED SIV VACCINES$403,625
P01 · FY2000 · AI
CORRELATES OF EFFICACY OF VEE-BASED SIV VACCINES$403,624
P01 · FY2000 · AI
NOVEL VIRAL VECTORS FOR AIDS VACCINES$167,178
P01 · FY2000 · AI
EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MODELS$0
N01 · FY2000 · AI